These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35068557)

  • 41. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule.
    Thiry J; Kok MG; Collard L; Frère A; Krier F; Fillet M; Evrard B
    Eur J Pharm Sci; 2017 Mar; 99():1-8. PubMed ID: 27951411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved absorption of β-carotene by encapsulation in an oil-in-water nanoemulsion containing tea polyphenols in the aqueous phase.
    Meng Q; Long P; Zhou J; Ho CT; Zou X; Chen B; Zhang L
    Food Res Int; 2019 Feb; 116():731-736. PubMed ID: 30717002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced dissolution and bioavailability of Nateglinide by microenvironmental pH-regulated ternary solid dispersion: in-vitro and in-vivo evaluation.
    Wairkar S; Gaud R; Jadhav N
    J Pharm Pharmacol; 2017 Sep; 69(9):1099-1109. PubMed ID: 28590055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.
    Feng J; Xu L; Gao R; Luo Y; Tang X
    Drug Dev Ind Pharm; 2012 Jun; 38(6):735-43. PubMed ID: 21999610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improvement of dissolution and bioavailability of Ginsenosides by hot melt extrusion and cogrinding.
    Luo Y; Xu L; Xu M; Tao X; Ai R; Tang X
    Drug Dev Ind Pharm; 2013 Jan; 39(1):109-16. PubMed ID: 22339205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of three different types of cilostazol-loaded solid dispersion: Physicochemical characterization and pharmacokinetics in rats.
    Mustapha O; Kim KS; Shafique S; Kim DS; Jin SG; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Choi HG
    Colloids Surf B Biointerfaces; 2017 Jun; 154():89-95. PubMed ID: 28324691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.
    Shi Q; Li F; Yeh S; Moinuddin SM; Xin J; Xu J; Chen H; Ling B
    AAPS PharmSciTech; 2021 Dec; 23(1):16. PubMed ID: 34893936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Encapsulation of Solid Dispersion in Solid Lipid Particles for Dissolution Enhancement of Poorly Water-Soluble Drug.
    My Tran KT; Vo TV; Lee BJ; Duan W; Ha-Lien Tran P; Truong-Dinh Tran T
    Curr Drug Deliv; 2018; 15(4):576-584. PubMed ID: 28595530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel nanocrystal-based solid dispersion with high drug loading, enhanced dissolution, and bioavailability of andrographolide.
    Ma Y; Yang Y; Xie J; Xu J; Yue P; Yang M
    Int J Nanomedicine; 2018; 13():3763-3779. PubMed ID: 29988798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability.
    Zhang F; Mao J; Tian G; Jiang H; Jin Q
    AAPS PharmSciTech; 2022 Jan; 23(1):65. PubMed ID: 35102461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Polymers on the Drug Solubility and Dissolution Enhancement of Poorly Water-Soluble Rivaroxaban.
    Choi MJ; Woo MR; Choi HG; Jin SG
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir.
    Sinha S; Ali M; Baboota S; Ahuja A; Kumar A; Ali J
    AAPS PharmSciTech; 2010 Jun; 11(2):518-27. PubMed ID: 20238187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate.
    Jung HJ; Ahn HI; Park JY; Ho MJ; Lee DR; Cho HR; Park JS; Choi YS; Kang MJ
    Int J Biol Macromol; 2016 Feb; 83():282-7. PubMed ID: 26642839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
    Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
    Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364.
    Sotthivirat S; McKelvey C; Moser J; Rege B; Xu W; Zhang D
    Int J Pharm; 2013 Aug; 452(1-2):73-81. PubMed ID: 23651642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
    Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
    Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of Fast-Dissolving Amorphous Solid Dispersion of Itraconazole by Melt Extrusion of its Mixture with Weak Organic Carboxylic Acid and Polymer.
    Parikh T; Serajuddin ATM
    Pharm Res; 2018 Apr; 35(7):127. PubMed ID: 29696402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A combined mathematical model linking the formation of amorphous solid dispersions with hot-melt-extrusion process parameters.
    Schittny A; Ogawa H; Huwyler J; Puchkov M
    Eur J Pharm Biopharm; 2018 Nov; 132():127-145. PubMed ID: 30240820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.